ribavirin has been researched along with Diathesis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Liu, M; Peng, H; Peng, J; Wang, Y; Xu, H; Xu, Q | 1 |
| Deng, XZ; Ding, WL; Li, GT; Wang, LJ; Xiao, W; Zhang, GQ; Zhang, JH; Zhou, ZX; Zhu, DY; Zhu, YM | 1 |
| Domínguez López, SL; Fernández Sierra, MA; Jiménez Romano, E; Molina Rueda, MJ | 1 |
| Ascione, T; Borgia, G; Buonomo, AR; Calò, F; Coppola, N; De Pascalis, S; de Stefano, G; Di Caprio, G; Federico, A; Filippini, P; Gaeta, GB; Gentile, I; Martini, S; Messina, V; Minichini, C; Persico, M; Rinaldi, L; Sangiovanni, V; Stanzione, M; Starace, M; Stornaiuolo, G; Zampino, R | 1 |
| Arias, A; Benítez-Gutiérrez, L; Citores, MJ; Cuervas-Mons, V; de Mendoza, C; Esposito, I; Requena, S; Soriano, V; Treviño, A | 1 |
| Garcia, G; Garcia, RT; Keeffe, EB; Levitt, BS; Li, J; Nguyen, HA; Nguyen, KK; Nguyen, MH; Nguyen, NH; Trinh, HN; Vutien, P | 1 |
| Bukh, J | 1 |
| Baur, K; Geier, A; Rau, M | 1 |
| Golzman, G; Hallevy, C; Herishanu, Y; Medvedovsky, M; Vander, T | 1 |
| Delahooke, TE; Hayes, PC; Kilpatrick, DC; Koch, C; Turner, ML | 1 |
| Medic-Mijacevic, L; Milicevic, I; Mostarica-Stojkovic, M; Pejanovic, V; Pekovic, S; Rakic, L; Stojiljkovic, M; Stosic-Grujicic, S; Subasic, S | 1 |
| Hokari, A; Zeniya, M | 1 |
| Ammassari, A; Giuliani, M; Lacaita, MG; Lajolo, C; Sartorio, A; Scivetti, M; Tamburrini, E; Tumbarello, M | 1 |
| Jacobs, JL | 1 |
4 review(s) available for ribavirin and Diathesis
| Article | Year |
|---|---|
Animal models for the study of hepatitis C virus infection and related liver disease.
Topics: Animals; Antibodies, Neutralizing; Antiviral Agents; Carcinoma, Hepatocellular; Cercopithecidae; Disease Models, Animal; Disease Susceptibility; Hepatitis Antibodies; Hepatitis C; Humans; Immunity, Innate; Interferon-alpha; Liver Diseases; Liver Neoplasms; Mice; Mice, SCID; Pan troglodytes; Platyrrhini; Ribavirin; Virus Replication | 2012 |
Host genetic variants in the pathogenesis of hepatitis C.
Topics: Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Disease Susceptibility; Genetic Predisposition to Disease; Hepacivirus; Hepatitis C; Host-Pathogen Interactions; Humans; Interferons; Interleukins; Membrane Transport Proteins; Pyrophosphatases; Receptors, Calcitriol; Ribavirin; Treatment Outcome | 2012 |
[Difference between autoimmune hepatitis (AIH) with and without hepatitis C virus (HCV)].
Topics: Adrenal Cortex Hormones; Antiviral Agents; Autoantibodies; Azathioprine; Disease Susceptibility; Drug Therapy, Combination; Hepatitis C, Chronic; Hepatitis, Autoimmune; HLA-DR4 Antigen; Humans; Immunosuppressive Agents; Interferons; Ribavirin | 2004 |
Immunologic developments in AIDS--1987.
Topics: Acquired Immunodeficiency Syndrome; Animals; Biological Factors; Clinical Trials as Topic; Colony-Stimulating Factors; Cytokines; Disease Models, Animal; Disease Susceptibility; Ethylenes; Genes, Viral; Haplorhini; Hematopoietic Stem Cells; HIV; HIV Antibodies; HIV Antigens; Humans; Mice; Receptors, HIV; Receptors, Virus; Recombinant Proteins; Retroviridae Infections; Ribavirin; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Proteins | 1989 |
1 trial(s) available for ribavirin and Diathesis
| Article | Year |
|---|---|
Immunologic developments in AIDS--1987.
Topics: Acquired Immunodeficiency Syndrome; Animals; Biological Factors; Clinical Trials as Topic; Colony-Stimulating Factors; Cytokines; Disease Models, Animal; Disease Susceptibility; Ethylenes; Genes, Viral; Haplorhini; Hematopoietic Stem Cells; HIV; HIV Antibodies; HIV Antigens; Humans; Mice; Receptors, HIV; Receptors, Virus; Recombinant Proteins; Retroviridae Infections; Ribavirin; Simian Immunodeficiency Virus; T-Lymphocytes; Viral Proteins | 1989 |
10 other study(ies) available for ribavirin and Diathesis
| Article | Year |
|---|---|
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes.
Topics: Adolescent; Antiviral Agents; Betacoronavirus; Child; Child, Preschool; China; Coronavirus Infections; COVID-19; Disease Susceptibility; Female; Hospitals, Pediatric; Humans; Infant; Interferon-alpha; Length of Stay; Male; Pandemics; Pediatricians; Pneumonia, Viral; Proportional Hazards Models; Retrospective Studies; Ribavirin; SARS-CoV-2; Severity of Illness Index | 2020 |
Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.
Topics: Adolescent; Adult; Aged; Antibodies, Viral; Antiviral Agents; Asian People; China; Disease Susceptibility; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Single Nucleotide; Ribavirin; Sustained Virologic Response; T-Box Domain Proteins; Viral Core Proteins; Young Adult | 2018 |
[Approach to a respiratory syncytial virus outbreak related to medical care in hematology].
Topics: Adult; Antiviral Agents; Bronchial Spasm; Cross Infection; Disease Outbreaks; Disease Susceptibility; Female; Hand Hygiene; Hematologic Neoplasms; Hematology; Hospital Departments; Hospitals, University; Humans; Infection Control; Male; Middle Aged; Respiratory Syncytial Virus Infections; Ribavirin | 2015 |
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.
Topics: Aged; Alleles; Anemia; Antiviral Agents; Disease Susceptibility; Drug Therapy, Combination; Enzyme Activation; Female; Gene Frequency; Genotype; Hepatitis C, Chronic; Humans; Inosine Triphosphatase; Liver Cirrhosis; Male; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Pyrophosphatases; Ribavirin; Risk Factors; Severity of Illness Index | 2017 |
Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C.
Topics: Adult; Aged; Alleles; Anemia, Hemolytic; Antiviral Agents; Disease Susceptibility; Female; Genotype; Hepatitis C, Chronic; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrophosphatases; Retrospective Studies; Ribavirin | 2017 |
Similar treatment response to peginterferon and ribavirin in Asian and Caucasian patients with chronic hepatitis C.
Topics: Adult; Analysis of Variance; Antiviral Agents; Asian People; Cohort Studies; Confidence Intervals; Disease Susceptibility; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Patient Compliance; Polyethylene Glycols; Probability; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Assessment; Treatment Outcome; White People | 2010 |
Listeria monocytogenes meningitis in a patient with chronic hepatitis C infection, treated by interferon alfa and ribavirin.
Topics: Adult; Anti-Bacterial Agents; Antiviral Agents; Disease Susceptibility; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Listeria monocytogenes; Listeriosis; Meningitis; Ribavirin | 2003 |
Mannan-binding lectin and hepatitis C infection.
Topics: Adult; Aged; Antiviral Agents; Case-Control Studies; Disease Progression; Disease Susceptibility; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Mannose-Binding Lectin; Middle Aged; Ribavirin | 2003 |
Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
Topics: Adjuvants, Immunologic; Animals; Demyelinating Diseases; Disease Models, Animal; Disease Susceptibility; Encephalomyelitis, Autoimmune, Experimental; Female; Immunosuppressive Agents; Macrophages; Microglia; Neuroprotective Agents; Rats; Rats, Inbred Strains; Ribavirin; Spinal Cord | 2003 |
Oral lesions in HIV and HCV co-infected individuals in HAART era.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Antiretroviral Therapy, Highly Active; Antiviral Agents; Case-Control Studies; CD4 Lymphocyte Count; Coitus; Disease Susceptibility; Feeding Behavior; Female; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Middle Aged; Mouth Diseases; Mouthwashes; Ribavirin; Risk Factors; Smoking; Substance Abuse, Intravenous; Time Factors; Viral Load; Young Adult | 2008 |